Retracted: Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans

Soo Hyeon Bae; Wan-Su Park; Seunghoon Han; Gab-Jin Park; Jongtae Lee; Taegon Hong; Sangil Jeon; Dong-Seok Yim

doi:10.1002/bdd.2060

Retracted: Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans

Biopharm Drug Dispos. 2017 Jul;38(5):363. doi: 10.1002/bdd.2060. Epub 2017 Feb 6.

Authors

Soo Hyeon Bae^{1

2}, Wan-Su Park^{1

2}, Seunghoon Han^{1

2}, Gab-Jin Park^{1

2}, Jongtae Lee^{1

2}, Taegon Hong³, Sangil Jeon⁴, Dong-Seok Yim^{1

2}

Affiliations

¹ Department of Clinical Pharmacology and Therapeutics, Seoul St Mary's Hospital, Seoul, Korea.
² PIPET (Pharmacometrics Institute for Practical Education and Training), College of Medicine, The Catholic University of Korea, Seoul, Korea.
³ Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
⁴ C&R Research Inc., Seoul, Korea.

PMID: 28027398
DOI: 10.1002/bdd.2060

Abstract

'Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans' by Soo Hyeon Bae, Wan-Su Park, Seunghoon Han, Gab-jin Park, Jongtae Lee, Taegon Hong, Sangil Jeon and Dong-Seok Yim The above article, published online on 06 February 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief, K. Sandy Pang, and John Wiley & Sons, Ltd. The authors retracted the paper due to errors associated with use of log D vs. log P of telmisartan as inputs of the PBPK model. The authors concluded that there are too many changes in the article to be resolved by an Erratum, and had requested a retraction. Reference Bae, S. H., Park, W.-S., Han, S., Park, G., Lee, J., Hong, T., Jeon, S., and Yim, D.-S. (2016) Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans. Biopharm. Drug Dispos., doi: 10.1002/bdd.2060.